Established in 2008, Zhangjiang, Shanghai, Viva Biotech (Shanghai) Ltd. is a leading open-access and innovation-driven technology platform company which is dedicated to pre-clinic drug discovery. 

请拖入内容到容器
请拖入内容到容器
请拖入内容到容器
Viva Biotech Awarded "Best Small and Medium Market Value Company"

Viva Biotech Awarded "Best Small and Medium Market Value Company"

The cradle for promising biotechnology startups all around the world.
QureBio’s Q-1802 Clinical Application Accepted by NMPA

QureBio’s Q-1802 Clinical Application Accepted by NMPA

The first Claudin 18.2/PD-L1 bispecific antibody drug accepted by NMPA.
Viva Biotech and Shanghai Biomedical Fund Announce the Cooperation to Jointly Build the Medical Innovation Achievement Transformation Platform

Viva Biotech and Shanghai Biomedical Fund Announce the Cooperation to Jointly Build the Medical Innovation Achievement Transformation Platform

Viva Biotech will give full play to its capabilities and advantages as a one-stop comprehensive service platform for drug R&D.
Viva Biotech and AlphaMa Reached Cooperation Agreement on IntelligentDEL (iDEL) Screening Platform

Viva Biotech and AlphaMa Reached Cooperation Agreement on IntelligentDEL (iDEL) Screening Platform

Viva Biotech will cooperate with AlphaMa to provide clients AI-based DNA coding compound library screening technology.
请拖入内容到容器